[(2R)-1-[7-bromo-4-[[1-(3,4,5-trimethoxyphenyl)imidazol-4-yl]amino]quinazolin-2-yl]pyrrolidin-2-yl]methanol
C25H27BrN6O4 — CID 142498784
Data last refreshed: (MolForge compound catalog, from PubChem)
About [(2R)-1-[7-bromo-4-[[1-(3,4,5-trimethoxyphenyl)imidazol-4-yl]amino]quinazolin-2-yl]pyrrolidin-2-yl]methanol
[(2R)-1-[7-bromo-4-[[1-(3,4,5-trimethoxyphenyl)imidazol-4-yl]amino]quinazolin-2-yl]pyrrolidin-2-yl]methanol (PubChem CID 142498784) has the molecular formula C25H27BrN6O4 and a molecular weight of 555.43 g/mol. Its IUPAC name is [(2R)-1-[7-bromo-4-[[1-(3,4,5-trimethoxyphenyl)imidazol-4-yl]amino]quinazolin-2-yl]pyrrolidin-2-yl]methanol.
Molecular Properties
| Compound Name | [(2R)-1-[7-bromo-4-[[1-(3,4,5-trimethoxyphenyl)imidazol-4-yl]amino]quinazolin-2-yl]pyrrolidin-2-yl]methanol |
|---|---|
| PubChem CID | 142498784 |
| Molecular Formula | C25H27BrN6O4 |
| Molecular Weight | 555.43 g/mol |
| Exact Mass | 554.13 |
| IUPAC Name | [(2R)-1-[7-bromo-4-[[1-(3,4,5-trimethoxyphenyl)imidazol-4-yl]amino]quinazolin-2-yl]pyrrolidin-2-yl]methanol |
| SMILES | COc1cc(-n2cnc(Nc3nc(N4CCC[C@@H]4CO)nc4cc(Br)ccc34)c2)cc(OC)c1OC |
| InChI | InChI=1S/C25H27BrN6O4/c1-34-20-10-17(11-21(35-2)23(20)36-3)31-12-22(27-14-31)29-24-18-7-6-15(26)9-19(18)28-25(30-24)32-8-4-5-16(32)13-33/h6-7,9-12,14,16,33H,4-5,8,13H2,1-3H3,(H,28,29,30)/t16-/m1/s1 |
| InChIKey | PVIWFSBAJLIEGH-MRXNPFEDSA-N |
| XLogP | 4.31 |
| TPSA | 106.79 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 36 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 555.43 |
| LogP ≤ 5 | 4.31 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142498784 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.